Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2010-8-11
pubmed:abstractText
To evaluate the efficacy of intravitreal bevacizumab (IVB) in eyes with polypoidal choroidal vasculopathy (PCV).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1613-2246
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
54
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
310-9
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:20700799-Aged, pubmed-meshheading:20700799-Aged, 80 and over, pubmed-meshheading:20700799-Angiogenesis Inhibitors, pubmed-meshheading:20700799-Antibodies, Monoclonal, pubmed-meshheading:20700799-Antibodies, Monoclonal, Humanized, pubmed-meshheading:20700799-Choroid, pubmed-meshheading:20700799-Choroid Diseases, pubmed-meshheading:20700799-Female, pubmed-meshheading:20700799-Fluorescein Angiography, pubmed-meshheading:20700799-Follow-Up Studies, pubmed-meshheading:20700799-Humans, pubmed-meshheading:20700799-Injections, pubmed-meshheading:20700799-Male, pubmed-meshheading:20700799-Middle Aged, pubmed-meshheading:20700799-Peripheral Vascular Diseases, pubmed-meshheading:20700799-Retreatment, pubmed-meshheading:20700799-Tomography, Optical Coherence, pubmed-meshheading:20700799-Treatment Outcome, pubmed-meshheading:20700799-Vascular Endothelial Growth Factor A, pubmed-meshheading:20700799-Visual Acuity, pubmed-meshheading:20700799-Vitreous Body
pubmed:year
2010
pubmed:articleTitle
Treatment of polypoidal choroidal vasculopathy by intravitreal injection of bevacizumab.
pubmed:affiliation
Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto, Japan. tujikawa@kuhp.kyoto-u.ac.jp
pubmed:publicationType
Journal Article